Thailand Life Sciences Gateway

Products & Innovation

Track product development, clinical trials, and innovation pipeline in Thailand's life sciences sector

Drug Development
156
In Various
Medical Devices
89
In FDA Review
Digital Health
67
In Market Ready
Diagnostics
45
In Clinical
Development Pipeline Funnel
Total: 357•Conversion: 19.2%
Research
125 products
35%
Preclinical
98 products
27%
Clinical Trials
76 products
21%
Regulatory Review
34 products
10%
Market Launch
24 products
7%
Research: 125
Preclinical: 98
-21.6%
Clinical Trials: 76
-22.4%
Regulatory Review: 34
-55.3%
Market Launch: 24
-29.4%

Conversion Insights

Overall conversion rate: 19.2%
Biggest drop-off: Clinical Trials → Regulatory Review (55.3%)
Investment by Development Stage
Innovation Metrics
Patents Filed
234
FDA Approvals
45
Export Markets
18
Success Rate
78%
Recent Milestones

CardioAI Scanner

FDA 510(k) clearance approved

1 day ago

CancerBlock-T

Phase III interim analysis positive

3 days ago

HealthTracker App

Reached 1M+ downloads

1 week ago

Featured Product Development

CancerBlock-T Development Timeline

2 Completed
1 In Progress
1 Upcoming

Phase II completed

completed

2024-Q1

Successfully completed Phase II clinical trials with 85% efficacy rate

Phase III enrollment

completed

2024-Q3

Enrolled 145 patients across 15 medical centers

Phase III interim analysis

in progress

2025-Q1

Currently analyzing interim results from ongoing Phase III trials

Product Portfolio4 products

CancerBlock-T

Cancer TherapyDrug

by BioPharma Innovations Co., Ltd.

Phase III Clinical Trial
75%

Revolutionary CAR-T cell therapy for treating aggressive blood cancers with personalized treatment approach.

Indication

Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma

Efficacy

90% complete remission rate

Timeline

Expected FDA submission Q2 2025

Investment

฿450M development cost

Development Milestones

2024-Q1

Phase II completed

2024-Q3

Phase III enrollment

2025-Q1

Phase III interim analysis

2025-Q2

FDA submission

Key Metrics

145

patients Enrolled

90%

success Rate

24 months

duration

฿450M

cost

2 Patents
3 Partners

CardioAI Scanner

Medical DeviceDiagnostic Equipment

by MedTech Solutions Ltd.

FDA Approved
100%

AI-powered cardiovascular diagnostic platform using machine learning for early detection of heart diseases.

Indication

Cardiovascular Disease Detection

Efficacy

95% diagnostic accuracy

Timeline

Commercial launch Q1 2025

Investment

฿180M development cost

Development Milestones

2023-Q2

CE Mark approval

2023-Q4

Clinical validation

2024-Q2

FDA 510(k) clearance

2025-Q1

Commercial launch

Key Metrics

95%

accuracy

3 minutes

scan Time

40%

cost Reduction

25 pilot sites

hospitals

2 Patents
3 Partners

ThaiHerb Plus

Traditional MedicineNutraceutical

by Thai Pharma Global

Market Launch
100%

Standardized traditional Thai herbal supplement line combining ancient wisdom with modern manufacturing.

Indication

Immune Support, Digestive Health

Efficacy

Clinical proven benefits

Timeline

Available in 500+ pharmacies

Investment

฿120M development cost

Development Milestones

2022-Q1

Research phase

2022-Q3

Clinical studies

2023-Q1

FDA Thailand approval

2023-Q3

Market launch

Key Metrics

500+

pharmacies

92%

satisfaction

+35% YoY

growth

5 countries

export

1 Patents
2 Partners

HealthTracker App

Digital HealthMobile Application

by Digital Health Innovations

Market Launch
100%

Comprehensive health monitoring mobile app with AI-powered insights and telemedicine integration.

Indication

Health Monitoring, Telemedicine

Efficacy

85% user engagement rate

Timeline

1M+ downloads achieved

Investment

฿45M development cost

Development Milestones

2023-Q1

Beta testing

2023-Q2

App store launch

2023-Q4

Telemedicine integration

2024-Q2

1M downloads milestone

Key Metrics

1.2M

downloads

4.8/5.0

rating

78%

retention

50K+

consultations

1 Patents
2 Partners